Latest period
$2.16B
YoY change
+69.5%
5Y CAGR
+25.0%
Peak year (2025)
$1.86B
Cumulative CapEx
$25.38B
CapEx history chart for Amgen (AMGN) from 1988 to 2025
Latest: $1.86B
CapEx growth chart for Amgen (AMGN) from 1988 to 2025
Latest: +69.5%
CapEx history table for Amgen (AMGN) from 1988 to 2025
| 2025 | $1.86B | +69.5% | +$762.00M | ||
| 2024 | $1.10B | -1.4% | −$16.00M | ||
| 2023 | $1.11B | +18.8% | +$176.00M | ||
| 2022 | $936.00M | +6.4% | +$56.00M | ||
| 2021 | $880.00M | +44.7% | +$272.00M | ||
| 2020 | $608.00M | -1.6% | −$10.00M | ||
| 2019 | $618.00M | -16.3% | −$120.00M | ||
| 2018 | $738.00M | +11.1% | +$74.00M | ||
| 2017 | $664.00M | -20.7% | −$173.00M | ||
| 2016 | $837.00M | +29.0% | +$188.00M | ||
| 2015 | $649.00M | -35.3% | −$354.00M | ||
| 2014 | $1.00B | +44.7% | +$310.00M | ||
| 2013 | $693.00M | +0.6% | +$4.00M | ||
| 2012 | $689.00M | +21.5% | +$122.00M | ||
| 2011 | $567.00M | -2.2% | −$13.00M | ||
| 2010 | $580.00M | +9.4% | +$50.00M | ||
| 2009 | $530.00M | -21.1% | −$142.00M | ||
| 2008 | $672.00M | -47.0% | −$595.00M | ||
| 2007 | $1.27B | +4.0% | +$49.00M | ||
| 2006 | $1.22B | +40.5% | +$351.00M | ||
| 2005 | $867.00M | -35.1% | −$469.00M | ||
| 2004 | $1.34B | -1.5% | −$20.80M | ||
| 2003 | $1.36B | +106.0% | +$698.30M | ||
| 2002 | $658.50M | +49.0% | +$216.70M | ||
| 2001 | $441.80M | +0.9% | +$4.10M | ||
| 2000 | $437.70M | +43.9% | +$133.50M | ||
| 1999 | $304.20M | -25.4% | −$103.60M | ||
| 1998 | $407.80M | +5.2% | +$20.00M | ||
| 1997 | $387.80M | +45.3% | +$120.90M | ||
| 1996 | $266.90M | +64.0% | +$104.20M | ||
| 1995 | $162.70M | +24.4% | +$31.90M | ||
| 1994 | $130.80M | -37.7% | −$79.10M | ||
| 1993 | $209.90M | -4.5% | −$9.90M | ||
| 1992 | $219.80M | +87.4% | +$102.50M | ||
| 1991 | $117.30M | +80.7% | +$52.40M | ||
| 1990 | $64.90M | +47.2% | +$20.80M | ||
| 1989 | $44.10M | +2.1% | +$900.00K | ||
| 1988 | $43.20M | — | — |
- 2025$1.86B+69.5%
- 2024$1.10B-1.4%
- 2023$1.11B+18.8%
- 2022$936.00M+6.4%
- 2021$880.00M+44.7%
- 2020$608.00M-1.6%
- 2019$618.00M-16.3%
- 2018$738.00M+11.1%
- 2017$664.00M-20.7%
- 2016$837.00M+29.0%
- 2015$649.00M-35.3%
- 2014$1.00B+44.7%
- 2013$693.00M+0.6%
- 2012$689.00M+21.5%
- 2011$567.00M-2.2%
- 2010$580.00M+9.4%
- 2009$530.00M-21.1%
- 2008$672.00M-47.0%
- 2007$1.27B+4.0%
- 2006$1.22B+40.5%
- 2005$867.00M-35.1%
- 2004$1.34B-1.5%
- 2003$1.36B+106.0%
- 2002$658.50M+49.0%
- 2001$441.80M+0.9%
- 2000$437.70M+43.9%
- 1999$304.20M-25.4%
- 1998$407.80M+5.2%
- 1997$387.80M+45.3%
- 1996$266.90M+64.0%
- 1995$162.70M+24.4%
- 1994$130.80M-37.7%
- 1993$209.90M-4.5%
- 1992$219.80M+87.4%
- 1991$117.30M+80.7%
- 1990$64.90M+47.2%
- 1989$44.10M+2.1%
- 1988$43.20M—
CapEx values are taken from Amgen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current CapEx (TTM) is $2.16B. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Amgen (AMGN) CapEx totalled $1.86B – surged 69.5% year-over-year.
Through 2020–2025 (5 years), Amgen CapEx delivered a +25.0% annualised rate; with mixed annual results across the window.
2025 marks the peak CapEx at $1.86B, with the historical low of $43.20M recorded in 1988.
Amgen Capital Expenditures by Year
Amgen Capital Expenditures 2025: $1.86B
Amgen posted CapEx of $1.86B in 2025, surged 69.5% from 2024. This figure represents the highest annual value in the available history.
Amgen Capital Expenditures 2024: $1.10B
In 2024, Amgen reported CapEx of $1.10B, edged down 1.4% below 2023.
Amgen Capital Expenditures 2023: $1.11B
Amgen CapEx in 2023 was $1.11B, grew 18.8% from 2022.
Amgen Capital Expenditures 2022: $936.00M
2022's CapEx for Amgen came in at $936.00M, grew 6.4% from 2021.
Amgen Capital Expenditures 2021: $880.00M
Amgen CapEx in 2021 was $880.00M.
See more financial history for Amgen (AMGN).
Sector peers by CapEx
Healthcare peers of Amgen (AMGN), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.52B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.21B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation